Nodal induced by hypoxia exposure contributes to dacarbazine resistance and the maintenance of stemness in melanoma cancer stem‑like cells

  • Authors:
    • Hong Li
    • Junjie Chen
    • Xiao Wang
    • Mei He
    • Zhenyu Zhang
    • Ying Cen
  • View Affiliations

  • Published online on: April 23, 2018     https://doi.org/10.3892/or.2018.6387
  • Pages: 2855-2864
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Nodal signaling has a critical role in the processes of embryogenesis and is necessary for maintaining cell stemness. However, its upregulation in melanoma is positively correlated with malignant potential, including cancer progression, metastasis and recurrence, and a recent report has revealed its role in promoting self‑renewal capacity in melanoma. Our study aimed to explore the effects of hypoxia exposure, which is one of the main causes of chemoresistance in melanoma, on the physiological processes of melanoma cancer stem‑like cells (CSCs) via regulating Nodal. A375 CSCs were enriched by culturing in serum‑free medium (SFM) and were analyzed for the expression levels of Nodal and its correlated proteins by semi‑quantitative western blotting. Lentiviral‑packaged Nodal coding sequence or short‑hairpin RNA (shRNA) was employed. After hypoxia exposure, the effects on glucose uptake, ATP production and O2 consumption were detected, and whether Nodal contributed to the proliferation, invasion, colony formation, self‑renewal capacity and chemoresistance was evaluated. We demonstrated that hypoxia exposure induced Nodal expression and activated the Smad2/3 pathway in A375 CSCs. Hypoxic‑induced Nodal partially promoted dacarbazine resistance, promoted invasion and self‑renewal capacity, but not proliferation which was further confirmed using Nodal knockdown. Blockage of Nodal signaling activity with the small‑molecule inhibitor SB431542 partially reversed Nodal‑induced chemoresistance. Nodal knockdown further sensitized A375 CSCs to dacarbazine after SB431542 pretreatment, indicating the involvement of proNodal in dacarbazine resistance. The introduction of mut‑proNodal induced chemoresistance further confirming the role of proNodal in this process. Taken together, our results demonstrated that Nodal induced by hypoxia exposure induced a malignant phenotype and chemoresistance in A375 CSCs, and proNodal also contributed to these processes, indicating that Nodal may be a potential therapeutic target for melanoma.

Introduction

Melanoma is one of the most aggressive types of skin cancer, and is the most deadly cutaneous neoplasm (1). In Western populations, although it accounts for less than 5% of all skin cancers, melanoma is one of the most common cancers among young adults and is one of the most common causes of death (2,3). Although melanoma is relatively rare, the increasing incidence over the past two decades has raised a major health concern, and once metastasis to distant organ occurs, the prognosis becomes extremely poor. Metastatic melanoma is resistant to many types of chemotherapeutic agents (4). To date, dacarbazine is considered to be the reference single agent for the management of advanced melanoma, and dacarbazine treatment exhibits effective responses in ~15–25% of patients (4). However, in metastatic melanoma patients, the 6-year median survival rate is extremely low (5).

The embryonic protein Nodal, belongs to the transforming growth factor (TGF)-β family, and plays critical roles in maintaining the self-renewal capacity and pluripotency of human embryonic stem cells (hESCs) (6,7). Emerging evidence has revealed its involvement in promoting the growth and progression of various types of cancer, including melanoma, glioma, breast, prostate and endometrial cancer (812). In both melanoma and its CSC subpopulation, accounting for 0.5% of melanoma cancer cells, activated Nodal/Activin signaling promotes tumorigenicity and maintains self-renewal capacity (13). In most cases, Nodal induces signal transduction after being cleaved by the proprotein convertases Furin or Pace4 to remove an N-terminal prodomain from precursor Nodal (proNodal) (14). A recent report also revealed that proNodal, but not mature Nodal, induces Nodal signaling transduction (15). However, it is still unknown which forms of Nodal, proNodal or mature Nodal regulates CSC properties.

Hypoxia, as one of the factors critical in the biological processes of CSCs, plays crucial roles in the activation of pathways involved in the maintenance of CSC functions (16,17), and is implicated in the development of chemoresistance. It was recently uncovered that hypoxia exposure converted non-cancer stem cells to CSCs in the melanoma cancer cell line A375 (18). Furthermore, Quail et al found that, in melanoma and breast cancer cells, hypoxia induced Nodal expression and caused promotion of cell invasion and angiogenic phenotypes, suggesting that Nodal may also be regulated by hypoxia in pancreatic CSCs (19).

In the present study, we investigated the effect of hypoxia exposure on Nodal expression and CSC properties in melanoma cancer cells. Our study revealed that hypoxia-induced Nodal enhanced CSC properties, including self-renewal capacity, sphere forming ability and chemoresistance. Moreover, both proNodal and mature Nodal induced by hypoxia exposure contributed to a higher tumorigenic potential.

Materials and methods

Cell culture, sphere formation and treatments

Human melanoma cancer cell line, A375, was purchased from the American Type Culture Collection (ATCC; Manassas, VA, USA) and cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 100 units/ml penicillin and 100 µg/ml streptomycin (Life Technologies; Thermo Fisher Scientific, Inc., Waltham, MA, USA).

For sphere formation, 2×105 cells were seeded in each 6-well plate and cultured with DMEM-F12 (1:1) medium containing human basic fibroblast growth factor (bFGF; 10 ng/ml; PeproTech, Rocky Hill, NJ, USA), human epidermal growth factor (EGF; 20 ng/ml; PeproTech) and 2% B27 (Life Technologies; Thermo Fisher Scientific, Inc.). Every three days, the medium was half-refreshed.

Hypoxic cultures were carried out in a humidified hypoxia workstation Invivo2 400 model (Baker Ruskinn Technology Ltd., Bridgend, UK). Briefly, medium was pre-exposed to 20% O2, 5% O2, 2% O2, 1% O2, or 0.5% O2 balanced with nitrogen and 5% CO2. Then, the cells were cultured in pre-treated medium and maintained in corresponding conditions for 24 or 48 h.

Western blotting

Cells were lysed with Laemmli sample buffer (50 mM Tris pH 6.8, 1.25% SDS, 10% glycerol) and heated at 100°C for 15 min for denaturalization. SDS-PAGE electrophoresis (6–12% gradient) was performed to fractionate total protein. Blots were then incubated with the following primary antibodies purchased from Abcam: CD44 (cat. no. ab157107), CD133 (cat. no. ab19898), Nanog (cat. no. ab21624), Sox2 (cat. no. ab97959), β-actin (cat. no. ab8226), cleaved Nodal (cat. no. ab81287), proNodal (cat. no. ab109317), ALK4 (cat. no. ab109300), ALK7 (cat. no. ab111121), Smad2/3 (cat. no. ab202445), p-Smad2 (cat. no. ab53100), p-Smad3 (cat. no. ab52903), HK-II (cat. no. ab104832), Glut-I (cat. no. ab115730), PDK-1 (cat. no. 110025) and HIF-1α (cat. no. ab113642). Primary antibodies were diluted at 1:1,000 in PBS and incubated with the blotted membrane at room temperature for 2 h. After three washes with PBS supplemented with 0.1% Tween-20 at room temperature, goat anti-mouse secondary antibody (cat. no. ab97040) (for β-actin, PDK-1 and HIF-1α) was used; for other antibodies, goat anti-rabbit secondary antibody (cat. no. ab7090) was used. β-actin was used as a loading control. Proteins were detected using ECL (Life Technologies; Thermo Fisher Scientific, Inc.) and visualized on X-ray film (Kodak, Japan).

Lentivirus production and cell infection

We obtained lentivirus-based shRNA constructs targeting human Nodal (shNodal; 5′-CCGGGCGGTTTCAGATGGACCTATTCTCGAGAATAGGTCCATCTGAAACCGCTTTTTG-3′) (LV-shNodal) as well as a control shRNA-expressing plasmid (shScrambled; 5′-CCGGCTATGGACGCTCTTATGTACTGGCGCCAGTACATAAGAGCGTCCATAGTTTTTG-3′) (LV-shScrambled). The oligonucleotides were cloned into the shRNA-pGCL-GFP lentiviral vector (Shanghai Genchem, Shanghai, China), respectively. Infectious viruses were produced by contransfecting the lentiviral vectors and packaging constructs (pHelper1.0 and pHelper2.0) into 293T cells using Lipofectamine™ reagent (Life Technologies; Thermo Fisher Scientific, Inc.).

The lentiviruses containing the Nodal coding sequences (LV-Nodal) for overexpressing Nodal were produced by Genomeditech Company (Shanghai, China), which were labeled with RFP. Lentiviruses containing the empty vector (LV-vector) were used as a negative control. Cells were transduced with the packaged lentiviruses at a multiplicity of infection (MOI) of 1:10 (cell:virus) (20) and 72-h later, the transduced cells were subsequently collected for further analysis.

Glucose uptake assay

For measuring glucose uptake, 1×106 cells were plated in 6-well plates overnight for attaching. The cells were incubated in glucose-free medium for 30 min at 37°C in a CO2 incubator and then 2-[3H]deoxyglucose at 1 µCi was added into the medium for a 2-h incubation. The cells were washed with ice-cold PBS three times, and transferred to scintillation vials for counting as described previously (21,22).

Lactate measurements

Cells (1×106) were plated in 6-well plates overnight and the medium was replaced with serum-free medium for 12 h. The supernatant was collected and diluted with PBS. For measuring lactate, the EnzyChrom™ L-Lactate assay kit (BioAssay Systems, Hayward, CA, USA) was employed following the manufacturer's instruction and was measured at 565 nm using a microplate reader (Synergy 2 Multi-Mode Microplate Reader; BioTek, Winooski, VT, USA).

ATP production

Cells (1×106) were plated in 6-well plates and allowed to adhere overnight. ATP Lite assay kit (PerkinElmer, Inc., Waltham, MA, USA) was employed to measure ATP production following the manufacturer's instruction.

Reactive oxygen species (ROS) detection

Total intracellular ROS was assessed by flow cytometry using the dichlorofluorescein (DCF) oxidation assay. The intracellular ROS oxidizes cleaved DCFH-DA which enters into cells. Target cells (5×105) were incubated with DCFH-DA (10 µM) for 1 h at 37°C, followed by 3 washes with ice-cold PBS, and ROS fluorescence was analyzed using 3 laser Navios flow cytometers (Beckman Coulter, Brea, CA, USA) with green fluorescence channel (FL1).

Cell death analysis

Cells (5×104) were collected, washed in PBS and stained with 1 µg/ml PI for 30 min in darkness. The stained cells were washed with ice-cold PBS for three times and analyzed by flow cytometry using 3 laser Navios flow cytometers. PI-positive cells were regarded as dead cells, and the percentage of dead cells was determined.

Cell viability assay

Cells were grown in 96-well plates, and viable cell numbers were determined with the CellTiter-Glo Luminescent Cell Viability Assay kit (Promega, Madison, WI, USA) following the manufacturer's guide.

Transwell cell invasion assays

Matrigel (Millipore Corp., Darmstadt, Germany) was diluted 1:2 in DMEM/F-12 and 60 µl of diluted Matrigel was added to the upper chamber of Transwell plates. Then, the chambers were incubated at 37°C in a 5% CO2 incubator for 2 h. Single-cells were resuspended in DMEM/F-12 and seeded into the upper chamber at a density of 2×104 cells/well. Subsequently, 600 µl of DMEM/F-12 supplemented with 20 ng/ml EGF, 10 ng/ml bFGF and 2% B27 was added to the lower chamber. After a 24-h incubation, the inserts were collected, and the cells on the lower surface were fixed in 4% paraformaldehyde and stained with crystal violet for 15 min. The cells in five random views were counted under a X71 (U-RFL-T) fluorescence microscope (Olympus, Melville, NY, USA).

Cloning of cleavage-resistant Nodal precursor (mut-proNodal)

The expression vector for mut-proNodal has been described (23) and the lentiviral vector containing mut-proNodal coding sequence (LV-mut-proNodal) was packaged as previously described (23).

Serial replating assay

Cells were replated at a clonal density (2,000 cells/well) and cultured in serum-free medium supplemented with 2% B-27, 10 ng/ml EGF and 20 ng/ml bFGF. The medium was half-replaced every 3 days. After 10 days, PBS-washed cells were fixed with 4% paraformaldehyde and stained with 0.1% crystal violet for 10 min and washed again with PBS, and the colonies were counted. For replating, the same amount of cells was plated in serum-free medium. After 10 days, the same procedure was performed three times.

Statistical analysis

All data were normalized to control values for each assay and are presented as mean ± standard deviation (SD). Multigroup comparisons of the means were carried out by one-way analysis of variance (ANOVA) test with post hoc contrasts by Student-Newman-Keuls test. Significance was chosen as P<0.05.

Results

Hypoxia upregulates the expression of Nodal protein in A375 CSCs

Serum-free medium culturing was used for enriching the stem-like cells from A375 cells in this study. After 14 days of culturing, spheres were completely formed and showed morphological similarity with embryonic tissues (Fig. 1A). In order to characterize the stem-like characteristics of the A375 subpopulation enriched using SFM culturing, we examined the expression levels of several stem cell markers (CD133, CD44, OCT4, Nanog and SOX2) and found that all were upregulated in the A375 CSCs compared to levels in the A375 cells at both the mRNA and protein levels (Fig. 1B and C). We further used in vitro serial replating assay to examine the self-renewal capacity of the A375 CSCs and the results confirmed the stem-like property (Fig. 1D). Nodal is reported to be restricted to embryonic tissues and hESCs, and re-emerges during tumorigenesis in several types of cancers (24). This promoted us to assess the differential expression of Nodal in A375 and A375 CSCs. Unexpectedly, compared to A375, no detectable difference in Nodal was found in the A375 CSCs (Fig. 1E).

For detecting the regulatory factor of tumor progression, hypoxia, which is an important environmental change in many cancers, was employed to determine its effect on the regulation of Nodal protein expression. We exposed A375 CSCs to varying levels of O2 for 24 and 48 h. Uncleaved Nodal protein (uncleaved NODAL, uNODAL, 39 kDa) and cleaved and secreted Nodal protein (cleaved NODAL, cNODAL, 15 kDa) were detected in whole cell lysate and in concentrated medium by ultrafiltration individually. The data showed that exposure of A375 CSCs to varying O2 concentrations (0.5–20% O2) for 24 and 48 h upregulated the Nodal protein level at concentrations ≤2% O2 (Fig. 1F). We also detected the expression pattern of Nodal receptor, ALK4/7, and no detectable changes were observed (Fig. 1F). Surprisingly, hypoxic exposure undetectably disturbed Nodal mRNA levels, indicating its post-transcriptional regulation on Nodal (data not shown). We then investigated whether Nodal/Nodal receptors are coupled to Smad signaling pathway by detecting phosphorylated Smad2/3 in A375 CSCs. Western blot analysis showed that Smad2, but not Smad3, was phosphorylated in A375 CSCs exposed to hypoxia at oxygen concentration of 0.5% and co-incubated with 100 ng/ml rhNodal (as a positive control) (Fig. 1G).

Hypoxic-induced Nodal enhances glucose uptake and promotes glycolysis

Nodal protein expression was reported to be positively correlated with hexokinase (HK)-II, glucose transporter (Glut)-1 and pyruvate dehydrogenase kinase (PDK)-1 by activating hypoxia-inducible factor (HIF)-1α, which is induced by hypoxic exposure and directly regulates energy metabolism (2527). Firstly, by introducing Nodal, we confirmed the positive correlation of Nodal with HK-II, Glut-1, PDK-1 and HIF-1α in A375 CSCs (Fig. 2A), and hypoxia exposure exerted similar effects. For ascertaining whether hypoxia-induced Nodal contributes to the upregulation of HIF-1α, HK-II, Glut-1 and PDK-1, in hypoxia-induced A375 CSCs transfected with Nodal shRNA, semi-quantitative western blotting was performed. As shown in Fig. 2B, hypoxia exposure markedly upregulated all these proteins, and Nodal knockdown detectably attenuated their protein levels. In hypoxic-exposed A375 CSCs, knockdown of Nodal significantly decreased 2-[3H]deoxyglucose uptake (Fig. 2C) and lactate accumulation (Fig. 2D). We next assessed whether Nodal contributes to the regulation of ATP production. As expected, Nodal knockdown negatively affected ATP production (Fig. 2E).

Nodal expression prevents excess ROS production and apoptosis in A375 CSCs

It has been reported that promotion of glycolysis prevents excess ROS production (28). Thus, we examined whether Nodal expression regulates ROS production. As shown in Fig. 3A, hypoxia exposure promoted ROS production and knockdown of Nodal markedly decreased accumulated ROS, which was confirmed quantitatively (Fig. 3B). As ROS is important for hypoxia-induced cell death, we analyzed whether Nodal modulates ROS-induced cell death in A375 CSCs. Knockdown of Nodal expression sensitized A375 CSCs against hypoxia-induced cell death, whereas the addition of ROS scavenger, N-acetyl-cysteine (NAC) slightly abolished the effect of Nodal, suggesting that Nodal enhances ROS detoxification mechanisms (Fig. 3C).

Hypoxic-induced Nodal partially contributes to decarbazine resistance in A375 CSCs

For investigating the roles of Nodal in A375 CSCs, we produced lentiviral particles coding for shRNA targeting the Nodal mRNA (LV-shNodal and LV-scrambled) and for overexpressing Nodal mRNA (LV-Nodal and LV-vector). The infectious efficacy and Nodal protein levels were detected (Fig. 4A and B). A375 CSCs were infected with LV-Nodal, LV-shNodal, or LV-Nodal/LV-shNodal to determine their IC50 value for dacarbazine, respectively. As expected, Nodal induced by hypoxic exposure and overexpressed by lentiviral infection desensitized A375 CSCs to dacarbazine, and knockdown of Nodal by LV-shNodal sensitized A375 CSCs to dacarbazine, indicating the critical role of Nodal protein in dacarbazine response (Fig. 4C). For further confirm the necessity of Nodal on dacarbazine desensitization, A375 CSCs were infected by LV-Nodal or LV-shNodal at MOI 10, 25, 50 and 100 to determine their IC50. With the decrease in Nodal protein, A375 CSCs presented more sensitivity to dacarbazine (Fig. 4D). However, in hypoxic-exposed A375 CSCs, upregulation of Nodal protein caused no detectable changes in the sensitization to dacarbazine, possibly because of its high endogenous level (data not shown). We then blocked the Nodal signal by SB431542 treatment in A375 CSCs to ascertain whether uncleaved precursor (proNodal) is involved in dacarbazine response. Surprisingly, after SB431542 blockage, knockdown of Nodal still sensitized hypoxic-exposed A375 CSCs to dacarbazine, indicating that proNodal also contributes to dacarbazine resistance in an undetermined manner (Fig. 4E).

Hypoxic-induced Nodal promotes cell invasion and maintains cell stemness, but not proliferation in A375 CSCs

Because of its tight association with malignancies in cancer and CSCs (29,30), we assessed the effects of hypoxic-induced Nodal on proliferation, invasion and preservation of stemness. Hypoxia exposure slightly affected the distribution of cell cycle phases and cell viability (data not shown), possibly due to high endogenous Nodal protein level. Then, the invasiveness affected by hypoxia exposure was detected, and the results showed that hypoxia exposure promoted invasion via upregulation of Nodal in A375 CSCs (Fig. 5A). For evaluating the capacity of self-renewal properties in A375 CSCs, colony formation and sphere formation assays were employed. The colony formation results demonstrated that both knockdown of Nodal expression and blockage by SB431542 in A375 CSCs apparently reduced colony formation (Fig. 5B). To further characterize the effects of hypoxia-induced Nodal on A375 CSCs, we overexpressed Nodal by lentiviral infection to simulate upregulation of hypoxic-induced Nodal, and to determine the sphere formation ability. Similarly, upregulated Nodal expression promoted the formation of spheres in the A375 CSCs in SFM (Fig. 5C). Simultaneously, both knockdown of Nodal expression and blockage by SB431542 in A375 CSCs caused dissociation of spheres (Fig. 4C). We counting the spheres ≥40 µm in diameter, and found that Nodal expression promoted the sphere forming rate, and Nodal knockdown and SB431542 exposure diminished the sphere forming rate (Fig. 5D). By considering the regulatory roles of Nodal on stemness maintenance, we next evaluated its effects on related genes, including CD44, CD133, Oct4, Nanog, and Sox2. Without disturbing Nanog and Sox2 levels, expression of Nodal was positively correlated with CD44, CD133 and Oct4 (Fig. 5E), which was consistent with its effect on spheroid morphology.

Both cleaved Nodal and proNodal contribute to dacarbazine resistance in A375 CSCs

Nodal is secreted as a precursor protein by endoproteolytic cleavage. It has been revealed that proNodal displays a subset of activities at physiological concentrations (3133). By considering the potential involvement of proNodal in physiological processes of A375 CSCs, we investigated whether the precursor and/or cleaved Nodal contribute to dacarbazine resistance. We first examined whether a recombinant Nodal cleavage mutant (mut-proNodal) which is resistant to specific cleavage can regulate dacarbazine sensitization in A375 CSCs. In A375 CSCs infected with LV-mut-proNodal, dacarbazine resistance was not disturbed, and SB431542-pretreated A375 CSCs were desensitized to dacarbazine after LV-mut-proNodal infection (Fig. 6A and B). For ascertaining whether mut-proNodal functions via recognizing the Nodal receptor, we exposed A375 CSCs to purified mut-proNodal and found that, rhNodal but not mut-proNodal exposure desensitized A375 CSCs to dacarbazine and was reversed by SB431542 co-exposure (Fig. 6C). For further confirming the apoptosis induced by dacarbazine treatment, Annexin V-PI staining was analyzed by flow cytometry. The results showed that, after 2 µM dacarbazine treatment for 24 h, introduction of mut-proNodal significantly reduced the apoptotic rate, with a robustness similar to that observed for LV-Nodal (Fig. 6D). Unexpectedly, introduction of mutant-proNodal failed to regulate self-renewal capacity and sphere formation (data not shown), indicating that proNodal might function via an independent undetermined manner.

Discussion

In the present study, we report that hypoxia exposure of A375 CSCs enhanced the CSC phenotype, tumor formation, invasion and chemoresistance. Hypoxia exposure upregulated Nodal protein and subsequently activated downstream signaling pathways. Blockage of Nodal pathway using ALK-4/5/7 inhibitor (SB431542; 10 µM) inhibited the CSC properties of hypoxia-exposed A375 CSCs. Moreover, it was revealed that hypoxic-induced Nodal enhanced glucose uptake and promoted glycolysis, and subsequently exerted protective effects on A375 CSCs via preventing ROS accumulation.

Nodal plays essential roles in the processes of embryonic development and maintains the pluripotent properties of stem cells during embryogenesis (34,35). Generally, Nodal expression is specifically expressed in embryonic tissues and hESCs and is undetectable in most highly differentiated tissues. However, it is found to be upregulated and contributes to increasing cancer cell aggressiveness, tumorigenicity and metastasis in several types of cancer, including melanoma, breast cancer and melanoma (3638). These findings indicate that the abnormal expression of Nodal promotes cancer cell proliferation, invasion and migration and inhibits apoptosis. It was reported that hypoxia exposure induces Nodal expression predominantly mediated via an HIF-1α-dependent pathway in melanoma cells. However, the effect of hypoxia exposure on melanoma CSCs is still unknown. In the present study, to further explore the regulatory effect of hypoxia exposure on Nodal expression and CSC properties in A375 CSCs, we exposed A375 CSCs to hypoxia and found that Nodal was induced after hypoxia exposure. Overexpression of Nodal increased the number and size of spheroids and promoted colony formation. In addition, semi-quantitative western blot analysis revealed that induced Nodal protein resulted in increased expression of CD44, CD133 and Oct4. For confirming whether induced Nodal expression by hypoxia exposure was responsible for these changes in expression, Nodal was knocked down using shNodal which subsequently resulted in a reversal of CSC properties in A375 CSCs in regards to the expression of CSC markers. ALK4/5/7 blockage using SB431542 presented similar effects on CSC properties of A375 CSCs with Nodal knockdown, revealing that Nodal signaling was necessary for regulating A375 CSC features.

Nodal is a member of the TGF-β superfamily of secreted proteins that signals through the serine/threonine kinase receptor family triggering the phosphorylation of Smad2 and 3 (6,7). It is worth testing the regulation of Nodal induced by hypoxia on TGF-β in further studies. It was reported that Nodal protein expression is positively correlated with HK-II, Glut-I and PDK-1 via activation of HIF-1α (24,25). Consistently, in the present study, it is found that, Nodal upregulated by hypoxia exposure promoted HK-II, Glut-1, PDK-1 and HIF-1α in A375 CSCs. Knockdown of Nodal remarkably attenuated hypoxic-induced upregulation of glycolysis-associated genes, indicating the critical role of Nodal in controlling glycolysis. By promoting glycolysis, hypoxic-induced Nodal prevented ROS accumulation and thus exerted protective effects on A375 CSCs. Instead of imaging ROS staining in spheres, we quantified ROS accumulation due to technical difficulty. However, it is still unknown how Nodal regulates this process.

Nodal is widely known as an inducer for mesendogermal genes and gastrulation movements within the epiblast after being activated and secreted after cleavage (32,39). It was also found that uncleaved Nodal (proNodal) governs the expression of downstream target genes, including sonic hedgehog (shh) and FGFR3 transcriptionally or post-transcriptionally, indicating that proNodal is potentially involved in physiological regulation (15). Processed Nodal activates Nodal/Activin signaling to maintain quiescence and chemoresistance in melanoma cancer stem cells (40), however, whether proNodal takes part in these processes remains unknown. In the present study, introduction of mut-proNodal desensitized A375 CSCs pretreated with 10 µM SB431542, indicating that it functions independent of the ALK4/7 receptor. This was further confirmed by exposure of A375 CSCs to purified rhNodal or mut-proNodal, in which mut-proNodal failed to influence the chemosensitivity of the A375 CSCs to dacarbazine. By performing apoptotic analysis, introduction of mut-proNodal significantly induced desensitization of A375 CSCs to dacarbazine, and revealed it functions intracellularly independent with cell surface receptor ALK4/7.

In conclusion, this study provides novel information concerning the effects of hypoxia exposure on Nodal expression and functions in A375 CSCs. Our results revealed that hypoxia exposure upregulated Nodal expression and activated Nodal signal on Smad2/3, contributed to maintain stemness and promotes malignanct potential, including invasion, sphere formation and colony formation. Importantly, uncleaved Nodal precursor, proNodal, desensitized A375 CSCs to dacarbazine, without disturbing self-renewal capacity and sphere formation, independent of mature Nodal receptor ALK4/7. Further research is required to reveal the novel mechanism. Taken together, we revealed that hypoxia-induced Nodal promoted malignant behavior and chemoresistance in melanoma cancer cell A375.

Acknowledgements

The authors thank Ms H.M. Shi for English editing.

Funding

No funding was received.

Availability of data and materials

The datasets used during the present study are available from the corresponding author upon reasonable request.

Authors' contributions

LH and CY conceived and designed the study. LH, CJJ, WX, HE and ZZY performed the experiments. LH wrote the manuscript. CY reviewed and edited the manuscript. All authors read and approved the manuscript and agree to be accountable for all aspects of the research in ensuring that the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Ethics approval and consent to participate

Cell lines were used in the study. No human tissues were used nor animal studies were carried out and thus no ethical approval was required.

Consent for publication

Not applicable.

Competing interests

All authors declare that they have no conflict of interests.

References

1 

Miller AJ and Mihm MC: Melanoma. N Engl J Med. 355:51–65. 2006. View Article : Google Scholar : PubMed/NCBI

2 

Godar DE: Worldwide increasing incidences of cutaneous malignant melanoma. J Skin Cancer. 2011:8584252011. View Article : Google Scholar : PubMed/NCBI

3 

Reed KB, Brewer JD, Lohse CM, Bringe KE, Pruitt CN and Gibson LE: Increasing incidence of melanoma among young adults: An epidemiological study in Olmsted County, Minnesota. Mayo Clin Proc. 87:328–334. 2012. View Article : Google Scholar : PubMed/NCBI

4 

Bedia C, Casas J, Andrieu-Abadie N, Fabriàs G and Levade T: Acid ceramidase expression modulates the sensitivity of A375 melanoma cells to decarbazine. J Biol Chem. 286:28200–28209. 2011. View Article : Google Scholar : PubMed/NCBI

5 

Mouawad R, Sebert M, Michels J, Bloch J, Spano JP and Khayat D: Treatment for metastatic malignant melanoma: Old drugs and new strategies. Crit Rev Oncol Hematol. 74:27–39. 2010. View Article : Google Scholar : PubMed/NCBI

6 

Brennan J, Norris DP and Robertson EJ: Nodal activity in the node governs left-right asymmetry. Genes Dev. 16:2339–2344. 2002. View Article : Google Scholar : PubMed/NCBI

7 

Takenaga M, Fukumoto M and Hori Y: Regulated nodal signaling promotes differentiation of the definitive endoderm and mesoderm from ES cells. J Cell Sci. 120:2078–2090. 2007. View Article : Google Scholar : PubMed/NCBI

8 

Topczewska JM, Postovit LM, Margaryan NV, Sam A, Hess AR, Wheaton WW, Nickoloff BJ, Topczewski J and Hendrix MJ: Embryonic and tumorigenic pathways converge via Nodal signaling: Role in melanoma aggressiveness. Nat Med. 12:925–932. 2006. View Article : Google Scholar : PubMed/NCBI

9 

Lee CC, Jan HJ, Lai JH, Ma HI, Hueng DY, Lee YC, Cheng YY, Liu LW, Wei HW and Lee HM: Nodal promotes growth and invasion in human gliomas. Oncogene. 29:3110–3123. 2010. View Article : Google Scholar : PubMed/NCBI

10 

Lawrence MG, Margaryan NV, Loessner D, Collins A, Kerr KM, Turner M, Seftor EA, Stephens CR, Lai J; APC BioResource, ; et al: Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells. Prostate. 71:1198–1209. 2011. View Article : Google Scholar : PubMed/NCBI

11 

Quail DF, Zhang G, Walsh LA, Siegers GM, Dieters-Castator DZ, Findlay SD, Broughton H, Putman DM, Hess DA and Postovit LM: Embryonic morphogen nodal promotes breast cancer growth and progression. PLoS One. 7:e482372012. View Article : Google Scholar : PubMed/NCBI

12 

Papageorgiou I, Nicholls PK, Wang F, Lackmann M, Makanji Y, Salamonsen LA, Robertson DM and Harrison CA: Expression of nodal signalling components in cycling human endometrium and in endometrial cancer. Reprod Biol Endocrinol. 7:1222009. View Article : Google Scholar : PubMed/NCBI

13 

Lonardo E, Hermann PC, Mueller MT, Huber S, Balic A, Miranda-Lorenzo I, Zagorac S, Alcala S, Rodriguez-Arabaolaza I, Ramirez JC, et al: Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy. Cell Stem Cell. 9:433–446. 2011. View Article : Google Scholar : PubMed/NCBI

14 

Fuerer C, Nostro MC and Constam DB: Nodal·Gdf1 heterodimers with bound prodomains enable serum-independent nodal signaling and endoderm differentiation. J Biol Chem. 289:17854–17871. 2014. View Article : Google Scholar : PubMed/NCBI

15 

Ellis PS, Burbridge S, Soubes S, Ohyama K, Ben-Haim N, Chen C, Dale K, Shen MM, Constam D and Placzek M: ProNodal acts via FGFR3 to govern duration of Shh expression in the prechordal mesoderm. Development. 142:3821–3832. 2015. View Article : Google Scholar : PubMed/NCBI

16 

Cabarcas SM, Mathews LA and Farrar WL: The cancer stem cell niche-there goes the neighborhood? Int J Cancer. 129:2315–2327. 2011. View Article : Google Scholar : PubMed/NCBI

17 

Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI

18 

Zhu H, Wang D, Liu Y, Su Z, Zhang L, Chen F, Zhou Y, Wu Y, Yu M, Zhang Z and Shao G: Role of the Hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133+ pancreatic cancer stem-like cells. Cancer Cell Int. 13:1192013. View Article : Google Scholar : PubMed/NCBI

19 

Quail DF, Taylor MJ, Walsh LA, Dieters-Castator D, Das P, Jewer M, Zhang G and Postovit LM: Low oxygen levels induce the expression of the embryonic morphogen Nodal. Mol Biol Cell. 22:4809–4821. 2011. View Article : Google Scholar : PubMed/NCBI

20 

Zhou S, Kurt-Jones EA, Cerny AM, Chan M, Bronson RT and Finberg RW: MyD88 intrinsically regulates CD4 T-cell responses. J Virol. 83:1625–1634. 2009. View Article : Google Scholar : PubMed/NCBI

21 

dos Santos SC, Tenreiro S, Palma M, Becker J and Sá-Correia I: Transcriptomic profiling of the Saccharomyces cerevisiae response to quinine reveals a glucose limitation response attributable to drug-induced inhibition of glucose uptake. Antimicrob Agents Chemother. 53:5213–5223. 2009. View Article : Google Scholar : PubMed/NCBI

22 

Walsh MC, Smits HP, Scholte M and van Dam K: Affinity of glucose transport in Saccharomyces cerevisiae is modulated during growth on glucose. J Bacteriol. 176:953–958. 1994. View Article : Google Scholar : PubMed/NCBI

23 

Constam DB and Robertson EJ: Regulation of bone morphogenetic protein activities by prodomains and proprotein convertases. J Cell Biol. 144:139–149. 1999. View Article : Google Scholar : PubMed/NCBI

24 

Vo BT and Khan SA: Expression of nodal and nodal receptors in prostate stem cells and prostate cancer cells: Autocrine effects on cell proliferation and migration. Prostate. 71:1084–1096. 2011. View Article : Google Scholar : PubMed/NCBI

25 

Lai JH, Jan HJ, Liu LW, Lee CC, Wang SG, Hueng DY, Cheng YY, Lee HM and Ma HI: Nodal regulates energy metabolism in glioma cells by inducing expression of hypoxia-inducible factor 1α. Neuro Oncol. 15:1330–1341. 2013. View Article : Google Scholar : PubMed/NCBI

26 

Papandreou I, Cairns RA, Fontana L, Lim AL and Denko NC: HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 3:187–197. 2006. View Article : Google Scholar : PubMed/NCBI

27 

Wang F, Zhang GY, Xing T, Lu ZY, Li JH, Peng C, Liu GH and Wang NS: Renalase contributes to the renal protection of delayed ischaemic preconditioning via the regulation of hypoxia-inducible factor-1α. J Cell Mol Med. 19:1400–1409. 2015. View Article : Google Scholar : PubMed/NCBI

28 

Jian SL, Chen WW, Su YC, Su YW, Chuang TH, Hsu SC and Huang LR: Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis. Cell Death Dis. 8:e27792017. View Article : Google Scholar : PubMed/NCBI

29 

Elliott RL and Blobe GC: Role of transforming growth factor beta in human cancer. J Clin Oncol. 23:2078–2093. 2005. View Article : Google Scholar : PubMed/NCBI

30 

Glasgow E and Mishra L: Transforming growth factor-beta signaling and ubiquitinators in cancer. Endocr Relat Cancer. 15:59–72. 2008. View Article : Google Scholar : PubMed/NCBI

31 

Beck S, Le Good JA, Guzman M, Ben Haim N, Roy K, Beermann F and Constam DB: Extraembryonic proteases regulate nodal signaling during gastrulation. Nat Cell Biol. 4:981–985. 2002. View Article : Google Scholar : PubMed/NCBI

32 

Ben-Haim N, Lu C, Guzman-Ayala M, Pescatore L, Mesnard D, Bischofberger M, Naef F, Robertson EJ and Constam DB: The nodal precursor acting via activing receptors induces mesoderm by maintaining a source of its convertases and BMP4. Dev Cell. 11:313–323. 2006. View Article : Google Scholar : PubMed/NCBI

33 

Eimon PM and Harland RM: Effects of heterodimerization and proteolytic processing on derriere and nodal activity: Implications for mesoderm induction in xenopus. Development. 129:3089–3103. 2002.PubMed/NCBI

34 

Strizzi L, Postovit LM, Margaryan NV, Seftor EA, Abbott DE, Seftor RE, Salomon DS and Hendrix MJ: Emerging roles of nodal and Cripto-1: From embryogenesis to breast cancer progression. Breast Dis. 29:91–103. 2008. View Article : Google Scholar : PubMed/NCBI

35 

Shen MM: Nodal signaling: Developmental roles and regulation. Development. 134:1023–1034. 2007. View Article : Google Scholar : PubMed/NCBI

36 

Duan W, Li R, Ma J, Lei J, Xu Q, Jiang Z, Nan L, Li X, Wang Z, Huo X, et al: Overexpression of nodal induces a metastatic phenotype in pancreatic cancer cells via the Smad2/3 pathway. Oncotarget. 6:1490–1506. 2015. View Article : Google Scholar : PubMed/NCBI

37 

Strizzi L, Postovit LM, Margaryan NV, Lipavsky A, Gadiot J, Blank C, Seftor RE, Seftor EA and Hendrix MJ: Nodal as a biomarker for melanoma progression and a new therapeutic target for clinical intervention. Expert Rev Dermatol. 4:67–78. 2009. View Article : Google Scholar : PubMed/NCBI

38 

Postovit LM, Margaryan NV, Seftor EA, Kirschmann DA, Lipavsky A, Wheaton WW, Abbott DE, Seftor RE and Hendrix MJ: Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci USA. 105:4329–4334. 2008. View Article : Google Scholar : PubMed/NCBI

39 

Brennan J, Lu CC, Norris DP, Rodriguez TA, Beddington RS and Robertson EJ: Nodal signaling in the epiblast patterns the early mouse embryo. Nature. 411:965–969. 2001. View Article : Google Scholar : PubMed/NCBI

40 

Cioffi M, Trabulo SM, Sanchez-Ripoll Y, Miranda-Lorenzo I, Lonardo E, Dorado J, Vieira Reis C, Ramirez JC, Hidalgo M, Aicher A, et al: The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells. Gut. 64:1936–1948. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

June 2018
Volume 39 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Li, H., Chen, J., Wang, X., He, M., Zhang, Z., & Cen, Y. (2018). Nodal induced by hypoxia exposure contributes to dacarbazine resistance and the maintenance of stemness in melanoma cancer stem‑like cells. Oncology Reports, 39, 2855-2864. https://doi.org/10.3892/or.2018.6387
MLA
Li, H., Chen, J., Wang, X., He, M., Zhang, Z., Cen, Y."Nodal induced by hypoxia exposure contributes to dacarbazine resistance and the maintenance of stemness in melanoma cancer stem‑like cells". Oncology Reports 39.6 (2018): 2855-2864.
Chicago
Li, H., Chen, J., Wang, X., He, M., Zhang, Z., Cen, Y."Nodal induced by hypoxia exposure contributes to dacarbazine resistance and the maintenance of stemness in melanoma cancer stem‑like cells". Oncology Reports 39, no. 6 (2018): 2855-2864. https://doi.org/10.3892/or.2018.6387